Oramed Pharmaceuticals
ORMP
#9134
Rank
S$0.22 B
Marketcap
S$5.06
Share price
0.77%
Change (1 day)
66.63%
Change (1 year)

Earnings for Oramed Pharmaceuticals (ORMP)

Earnings in 2026 (TTM): S$81 Million

According to Oramed Pharmaceuticals's latest financial reports the company's current earnings are N/A. In 2025 the company made an earning of S$80.23 Million, an increase over its 2024 earnings that were of -S$19.42 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Oramed Pharmaceuticals from 2006 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) S$81 M0.96%
2025 S$80.23 M-513.21%
2024 -S$19.42 Million-311.47%
2023 S$9.18 M-119.45%
2022 -S$47.21 Million39.17%
2021 -S$33.92 Million73.93%
2020 -S$19.51 Million18.53%
2019 -S$16.46 Million-16.62%
2018 -S$19.74 Million38.32%
2017 -S$14.27 Million12.51%
2016 -S$12.68 Million25.01%
2015 -S$10.15 Million18.18%
2014 -S$8.59 Million39.72%
2013 -S$6.15 Million46.4%
2012 -S$4.2 Million128.32%
2011 -S$1.84 Million-51.47%
2010 -S$3.79 Million35.21%
2009 -S$2.81 Million
2007 -S$4.41 Million607.04%
2006 -S$0.63 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Novo Nordisk
NVO
S$29.62 B 36,485.33%๐Ÿ‡ฉ๐Ÿ‡ฐ Denmark
Sanofi
SNY
S$10.03 B 12,296.78%๐Ÿ‡ซ๐Ÿ‡ท France
Ultragenyx Pharmaceutical
RARE
-S$0.58 Billion-811.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Lexicon Pharmaceuticals
LXRX
-S$78.77 Million-197.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Compugen
CGEN
S$44.95 M-44.47%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel